Grandview Asset Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-29,880
Closed -$988K 17
2019
Q4
$988K Sell
29,880
-687
-2% -$19.6K 0.94% 28
2019
Q3
$736K Sell
30,567
-2,330
-7% -$66.5K 0.67% 43
2019
Q2
$982K Sell
32,897
-4,275
-12% -$125K 0.91% 30
2019
Q1
$996K Sell
37,172
-400
-1% -$12.1K 0.92% 34
2018
Q4
$1.15M Buy
+37,572
New +$1.17M 1.22% 27

Other funds holding ATRC

Grandview Asset Management's ATRC Position: Q1 2020 in Review

Grandview Asset Management sold out of AtriCure (ATRC) in Q1 2020, closing a stake of 29,880 shares — an estimated $988K sold.

Grandview Asset Management first reported a position in ATRC in Q4 2018 and held it in 5 quarters. The position peaked at $1.15M in Q4 2018. 155 funds tracked by Wall St. Rank hold ATRC as of Q1 2020.

  • Grandview Asset Management reported no remaining AtriCure position as of Q1 2020 after selling out during the quarter.
  • Grandview Asset Management sold 29,880 AtriCure shares in Q1 2020, an estimated $988K.
  • Grandview Asset Management first reported a position in AtriCure in Q4 2018 and held it in 5 quarters.
  • Grandview Asset Management's AtriCure position peaked at $1.15M in Q4 2018.
  • 155 funds tracked by Wall St. Rank held AtriCure as of Q1 2020.

Based on Grandview Asset Management's 13F filing for Q1 2020, filed 9 Apr 2020.